The takeaway
JPMorgan International Research Enhanced Equity ETF shows a moderate seasonal pattern over 4 years of data — strongest in January (+5.1%) and softest in September (−1.7%).
Right now
In July, the fund has risen 75% of years, averaging +2.0% — essentially in line with the S&P 500.
The full picture
JPMorgan International Research Enhanced Equity ETF's most dependable month has been January, higher in 3 of 3 years; September has been its least reliable, up just 50% of the time.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Win rate % | ||||||||||||
| Median return % | ||||||||||||
| 2025 | ||||||||||||
| 2024 | ||||||||||||
| 2023 | ||||||||||||
| 2022 | — | — | — | — | — |
Month by month
The fund's clearest edge over the S&P 500 lands in January (+5.3 pts); it has trailed the market most in October (−1.6 pts).
“vs S&P” is JPMorgan International Research Enhanced Equity ETF’s average for a month minus the S&P 500’s average for that same month — isolating JPMorgan International Research Enhanced Equity ETF’s own seasonal edge from broad market drift.
Reality check
Over the last 3 years, January has closed higher 100% of the time versus 100% across the last 4 years — the pattern is holding.
Figures are the typical (median) January return and how often it rose — the last 3 years versus the last 4(the heatmap’s default window). This verdict stays anchored to that 4-year window even if you zoom the chart, so it never disagrees with the badges above.
In plain English
This is a fund you can almost set a calendar by, and January is the anchor — it has closed higher in all 3 Januaries, the steadiest beat on its year.
The strength looks broad-based rather than freakish: its average (+5.1%) and median (+5.5%) sit close together, so no single blow-out year is flattering the figure. Better still, that strength is the fund's own and not just a buoyant market — January has outpaced the S&P 500 by +5.3 points on average. Few peers keep such company in January — the typical stock clears it just 53% of the time.
January anchors a run, too: the January-through-May window has been the fund's reliable season. On the other side of the ledger, September has been the soft spot — the weakest of 2 months that average a loss (−1.7%), and the edge isn't year-round — the fund has trailed the S&P 500 in October, September, and April.
For a fund this dependable in January, the sharper question is the rest of the year — outside its strong stretch, the calendar gives far less to lean on. With a short 4-year record, the signal is best held loosely.
Short answers on the fund's best month (January), its worst (September), and whether it really trades seasonally.
Yes, to a moderate degree. Since 2022 its best month (January, +5.1%) has run well ahead of its worst (September, −1.7%) — the heatmap above shows how steady that gap has been year to year.
January has been the strongest, averaging +5.1% and closing higher in all 3 years on record since 2022.
It's the weakest, averaging −1.7% — historically a soft spot, though it still varies from year to year.
Explore
These names have the strongest July track records on record — a starting point for comparison.
Before you trade